Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick L Ruberg

Showing results (81-90 of 109) with videos related to

Pageof 11
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|December 7, 2019
Quantitative [<sup>18</sup>F]florbetapir PET/CT may identify lung involvement in patients with systemic AL amyloidosisYiu Ming Khor, Sarah Cuddy, Hendrik J Harms, et al.
JACC. Cardiovascular Imaging|July 13, 2024
Myocardial Characteristics, Cardiac Structure, and Cardiac Function in Systemic Light-Chain AmyloidosisOlivier F Clerc, Sarah A M Cuddy, Michael Jerosch-Herold, et al.
The American Journal of Cardiology|November 24, 2024
The Impact of Active Ascertainment on Sex-Specific Differences in the Prevalence and Phenotype of Transthyretin Cardiac Amyloidosis: The Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations StudyNicholas Chan, Andrew J Einstein, Sergio Teruya, et al.
Medrxiv : the Preprint Server for Health Sciences|October 24, 2023
Myocardial Characterization for Early Diagnosis, Treatment Response Monitoring, and Risk Assessment in Systemic Light-Chain AmyloidosisOlivier F Clerc, Sarah A M Cuddy, Michael Jerosch-Herold, et al.
Frontiers in Cardiovascular Medicine|June 14, 2024
Mechanisms of left ventricular systolic dysfunction in light chain amyloidosis: a multiparametric cardiac MRI studyEthan Katznelson, Michael Jerosch-Herold, Sarah A M Cuddy, et al.
Journal of Cardiac Failure|May 13, 2024
Unlocking Diversity in Cardiovascular Clinical Research: Lessons from the Screening for Cardiac Amyloidosis With Nuclear Imaging in a Minority Populations StudyAbdirahman Wardhere, Dimitrios Bampatsias, Elizabeth Cohn, et al.
Journal of the American Heart Association|April 17, 2023
Design and Rationale the SCAN-MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) StudyFrederick L Ruberg, William S Blaner, Codruta Chiuzan, et al.
JACC. Cardiovascular Imaging|May 18, 2020
Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?Sarah A M Cuddy, Paco E Bravo, Rodney H Falk, et al.
European Heart Journal. Cardiovascular Imaging|January 9, 2024
Quantification of right ventricular amyloid burden with 18F-florbetapir positron emission tomography/computed tomography and its association with right ventricular dysfunction and outcomes in light-chain amyloidosisYesh Datar, Olivier F Clerc, Sarah A M Cuddy, et al.
Journal of Alzheimer'S Disease : JAD|March 12, 2016
The Vanderbilt Memory & Aging Project: Study Design and Baseline Cohort OverviewAngela L Jefferson, Katherine A Gifford, Lealani Mae Y Acosta, et al.
Pageof 11

Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
European Journal of Nuclear Medicine and Molecular Imaging|December 7, 2019
Quantitative [<sup>18</sup>F]florbetapir PET/CT may identify lung involvement in patients with systemic AL amyloidosisYiu Ming Khor, Sarah Cuddy, Hendrik J Harms, et al.
JACC. Cardiovascular Imaging|July 13, 2024
Myocardial Characteristics, Cardiac Structure, and Cardiac Function in Systemic Light-Chain AmyloidosisOlivier F Clerc, Sarah A M Cuddy, Michael Jerosch-Herold, et al.
The American Journal of Cardiology|November 24, 2024
The Impact of Active Ascertainment on Sex-Specific Differences in the Prevalence and Phenotype of Transthyretin Cardiac Amyloidosis: The Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations StudyNicholas Chan, Andrew J Einstein, Sergio Teruya, et al.
Medrxiv : the Preprint Server for Health Sciences|October 24, 2023
Myocardial Characterization for Early Diagnosis, Treatment Response Monitoring, and Risk Assessment in Systemic Light-Chain AmyloidosisOlivier F Clerc, Sarah A M Cuddy, Michael Jerosch-Herold, et al.
Frontiers in Cardiovascular Medicine|June 14, 2024
Mechanisms of left ventricular systolic dysfunction in light chain amyloidosis: a multiparametric cardiac MRI studyEthan Katznelson, Michael Jerosch-Herold, Sarah A M Cuddy, et al.
Journal of Cardiac Failure|May 13, 2024
Unlocking Diversity in Cardiovascular Clinical Research: Lessons from the Screening for Cardiac Amyloidosis With Nuclear Imaging in a Minority Populations StudyAbdirahman Wardhere, Dimitrios Bampatsias, Elizabeth Cohn, et al.
Journal of the American Heart Association|April 17, 2023
Design and Rationale the SCAN-MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) StudyFrederick L Ruberg, William S Blaner, Codruta Chiuzan, et al.
JACC. Cardiovascular Imaging|May 18, 2020
Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?Sarah A M Cuddy, Paco E Bravo, Rodney H Falk, et al.
European Heart Journal. Cardiovascular Imaging|January 9, 2024
Quantification of right ventricular amyloid burden with 18F-florbetapir positron emission tomography/computed tomography and its association with right ventricular dysfunction and outcomes in light-chain amyloidosisYesh Datar, Olivier F Clerc, Sarah A M Cuddy, et al.
Journal of Alzheimer'S Disease : JAD|March 12, 2016
The Vanderbilt Memory & Aging Project: Study Design and Baseline Cohort OverviewAngela L Jefferson, Katherine A Gifford, Lealani Mae Y Acosta, et al.
Pageof 11